Navigation Links
IU analysis changing diagnosis and management of initial UTIs in young children
Date:8/30/2011

INDIANAPOLIS Analysis by Indiana University School of Medicine researchers of ten years of scientific studies has resulted in changes in American Academy of Pediatrics recommendations for how initial urinary tract infection in infants and toddlers is diagnosed and treated. This change will affect thousands of children every year.

The findings of the IU School of Medicine investigators argue against exposing all young children who are diagnosed with an initial urinary tract infection (UTI) to a painful radiologic test and against prescribing prophylactic antibiotic treatment that may extend for years -- the diagnosis and management tools indicated in the American Academy of Pediatrics' current guideline, established in 1999. The new study was conducted at the request of the AAP.

As a result of these findings, the AAP has updated its practice guideline on the diagnosis and management of initial UTIs in children aged two to 24 months. The report and the new AAP guideline appear in the September issue of the journal Pediatrics.

UTIs are one of the most common bacterial infections in babies and toddlers. Five percent of children in this age group with fever and no other obvious fever source have UTI. Diagnosis and management are clinically challenging because the patients are unable to express their symptoms. Repeated UTIs can lead to kidney scarring and life-long decreased kidney function.

In the 1999 guideline a radiologic test called a voiding cystourethrogram (VCUG) was recommended for young children after a first UTI. This was done to identify children with urine refluxing back up to the kidney. When identified, most of these children were started on prophylactic antibiotics in an attempt to prevent repeated episodes of UTI. But when the IU researchers reviewed studies done in the decade following the old 1999 guidelines, they found no benefit to long-term prophylactic antibiotics. Given that antibiotics do not work, they determined there was no reason to put all these children through the pain and radiation of the VCUG.

"If there is no obvious source of fever, the pediatrician needs to think UTI and needs to test for it. But we need to now change what we do after we have treated that first episode of UTI. We, as physicians, have been fooling ourselves by putting young patients on long-term antibiotics and thinking that would prevent the patient from getting another UTI," said S. Maria Finnell, M.D., assistant professor of pediatrics at the IU School of Medicine, lead author of the technical report and an author of the AAP policy statement.

"Technical ReportDiagnosis and Management of an Initial UTI in Febrile Infants and Young Children" accompanies the AAP's new clinical practice guidelines "Clinical Practice GuidelineDiagnosis and Management of Initial UTIs in Febrile Infants and Children Aged 2 to 24 Months."

"The AAP is the authoritative source of pediatric guidelines in the United States and beyond. This change in recommendations will have a substantial impact on clinical practice," said Stephen M. Downs, M.D., professor of pediatrics at the IU School of Medicine and co-author of the new technical report. Dr. Downs was the author of a 1999 technical report that informed the earlier AAP guideline.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related medicine news :

1. UBC researchers create more powerful lab-on-a-chip for genetic analysis
2. Localized reactive badger culling raises bovine tuberculosis risk, new analysis confirms
3. Novel analysis method organizes genomic cancer data
4. The Cancer Genome Atlas completes detailed ovarian cancer analysis
5. In a new post-hoc analysis, significantly more patients achieved blood sugar goals with JANUMET
6. Analysis finds mortality from all causes higher among hepatitis C-infected
7. Drug Marketing Often Targets Med Students: Analysis
8. Climate change analysis predicts increased fatalities from heat waves
9. Screening for hepatitis B may be cost-effective for more of the population, analysis shows
10. UCSF analysis shows newer surgery for neck pain may be better
11. Analysis of opioid prescription practices finds areas of concern
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
IU analysis changing diagnosis and management of initial UTIs in young children
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is ... to take the Diabetes Risk Test to find out if they are at risk ... Airports will light up the evening sky by programming the LAX pylons the color ...
(Date:3/28/2017)... YORK (PRWEB) , ... March 28, 2017 , ... ... NTX Technology™, is the first technology to directly address the resolution to globally ... NTX Technology™ is a patented compound of FDA and TTB approved ingredients that ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is ... Pharm.D., FASCP. The program was recently launched on March 1, and Dr. Wentz ... function. , Dr. Izabella Wentz is a licensed pharmacist and a foremost ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have soared 82% ... Trends Report). As travelers visit both urban destinations, they are faced with exploration ... exposure. In response, the outdoor industry has blurred the lines between fashion and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... SPRING, Md. , March 28, 2017 /PRNewswire-USNewswire/ ... approved Dupixent (dupilumab) injection to treat adults with ... patients whose eczema is not controlled adequately by ... are not advisable. Dupixent can be used with ... of Dupixent demonstrates our commitment to approving new ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... PHOENIX , March 28, 2017  Today, Allergy ... released a new white paper to underscore the ... latex in healthcare. Specifically, there is substantial confusion as to ... FDA has urged manufacturers to drop the term "latex free" ... of the challenge to ensure a product is completely devoid ...
Breaking Medicine Technology: